FOXO3 and prostate carcinoma: MiR-223-3p notably increased glucose depletion as well as lactate and ATP production in radioresistant prostate cancer cells, and the concomitant overexpression of FOXO3a attenuated miR-223-3p-induced glycolytic activation.